SCHEMBL931682

SCHEMBL931682

O=C(CN1CC2CC1CN2C(=O)O)NC1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 6/20 0.46
HPGD P15428 3/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C19 P33261 1/20 0.46
CHRM5 P08912 3/20 0.45
CHRM1 P11229 2/20 0.45
CHRM3 P20309 2/20 0.45
CHRM2 P08172 1/20 0.45
CHRM4 P08173 1/20 0.45
ALDH1A1 P00352 1/20 0.43
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA9 Q16790 2/20 0.41
KMT2A Q03164 2/20 0.41
EPHX1 P07099 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1554221 0.86 ALDH1A1 (0.48) SIGMAR1HPGDCHRM1CHRM3CHRM2
SCHEMBL26466767 0.80 SIGMAR1 (0.45) SIGMAR1HPGDCYP3A4CYP2C19CHRM5
SCHEMBL1555258 0.72 HPGD (0.49) SIGMAR1HPGDCYP3A4CYP2C19CHRM5
SCHEMBL1554899 0.70 EPHX1 (0.44) SIGMAR1HPGDALDH1A1EPHX1SMN1; SMN2
SCHEMBL5036242 0.69 ATM (0.32)
SCHEMBL13451969 0.67 AGL (0.35) CYP3A4
SCHEMBL6134967 0.67 HSD11B1 (0.40) KMT2AMEN1
SCHEMBL6479844 0.65 SIGMAR1 (0.75) SIGMAR1HPGDCYP3A4CYP2C19CHRM5
SCHEMBL3075216 0.65 EPHX1 (0.68) HPGDCYP3A4CYP2C19ALDH1A1KMT2A
SCHEMBL23612751 0.65 SIGMAR1 (0.71) SIGMAR1HPGDCYP3A4CYP2C19CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011000945-A9 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-04-07 WO disclosed
WO-2011000945-A2 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-01-06 WO disclosed